New Clinical Guidance: Stimulant Use
On behalf of the NYSDOH AI, lead authors Drs. Judith Griffin, Sara Lorenz Taki, and Timothy Wiegand, with the Substance Use…
Articles
Safer Substance Use Website is LIVE
Please see the “Safer Substance Use” website, designed by our colleagues at Yale School of Medicine to promote education about…
Improving Access to Methadone Treatment in the US
by Rachel Simon, MD and Aaron D. Fox, MD MS It was a Friday afternoon and the patient – a…
Methadone Reform Conference: September 2023
Dear colleagues, We are delighted to invite you to the upcoming conference, “Liberating Methadone: Building a Roadmap and Community for…
Methadone Treatment in Primary Care: Experience from Ontario, Canada 1980-2021
Update: June 5, 2023: Slides and Recording Now available. Download Slides Watch Webinar Webinar – Wednesday, May 31st @ 7pm…
New OASAS Medical Advisory Panel (MAP) Xylazine Guidance
OASAS has posted the new OASAS Medical Advisory Panel (MAP) Xylazine Guidance document. Please share widely with your staff. Please…